Chlamydia Trachomatis antibody

Catalog No. ABIN125981

The Mouse Monoclonal anti-Chlamydia Trachomatis antibody has been validated for IF and IHC (fro). It is suitable to detect Chlamydia Trachomatis in samples from Chlamydia trachomatis.

Quick Overview for Chlamydia Trachomatis antibody (ABIN125981)

Target: Chlamydia Trachomatis

Reactivity: Chlamydia trachomatis

Host: Mouse

Clonality: Monoclonal

Conjugate: This Chlamydia Trachomatis antibody is un-conjugated

Application: Immunofluorescence (IF), Immunohistochemistry (Frozen Sections) (IHC (fro))

Clone: ICK

Product Details anti-Chlamydia Trachomatis Antibody

Purification: Protein A affinity chromatography

Immunogen: Chlamydia antigen

Isotype: IgG1

Application Details

Application Notes: Immunofluorescence of cell culture: 1: 10. Immunohistochemistry on frozen tissue sections. Detection of chlamydia in clinical specimen after fixation with methanol/acetone: 1: 1.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user.

Restrictions: For Research Use only

Handling

Reconstitution: Restore in 1 mL dist. water

Buffer: PBS buffer, pH 7.4 containing 0.09 % NaN3, 0.5 % BSA

Preservative: Sodium azide

Precaution of Use: Use of sodium azide as a preservative will substantially inhibit the enzyme activity of horseradish peroxidase.

Handling Advice: Avoid repeated freezing and thawing.

Storage: 4 °C/-20 °C

Storage Comment: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Target Details for Chlamydia Trachomatis

Target: Chlamydia Trachomatis

Target Type: Bacteria

Background: Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5 % to 10 %. Chlamydia is one of the leading causes of blindness in underdeveloped countries.